Santoveña-Estévez, A.; Suárez-González, J.; Cáceres-Pérez, A.R.; Ruiz-Noda, Z.; Machado-Rodríguez, S.; Echezarreta, M.; Soriano, M.; Fariña, J.B.
Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics. Pharmaceutics 2020, 12, 195.
https://doi.org/10.3390/pharmaceutics12020195
AMA Style
Santoveña-Estévez A, Suárez-González J, Cáceres-Pérez AR, Ruiz-Noda Z, Machado-Rodríguez S, Echezarreta M, Soriano M, Fariña JB.
Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics. Pharmaceutics. 2020; 12(2):195.
https://doi.org/10.3390/pharmaceutics12020195
Chicago/Turabian Style
Santoveña-Estévez, Ana, Javier Suárez-González, Amor R. Cáceres-Pérez, Zuleima Ruiz-Noda, Sara Machado-Rodríguez, Magdalena Echezarreta, Mabel Soriano, and José B. Fariña.
2020. "Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics" Pharmaceutics 12, no. 2: 195.
https://doi.org/10.3390/pharmaceutics12020195
APA Style
Santoveña-Estévez, A., Suárez-González, J., Cáceres-Pérez, A. R., Ruiz-Noda, Z., Machado-Rodríguez, S., Echezarreta, M., Soriano, M., & Fariña, J. B.
(2020). Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics. Pharmaceutics, 12(2), 195.
https://doi.org/10.3390/pharmaceutics12020195